Armata Pharmaceuticals, Inc. (ARMP) stock
ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.87+0.15 (+4.03%)
Close on Nov 13, 2026Market cap $143.89MP/E –Yield –
Armata Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Armata Pharmaceuticals's enterprise value was $120.54M on Nov 11, 2026, against $253.85M a year earlier. Over the last 5 years it ranged from $16.10M to $383.31M, with a median of $94.07M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $120.54M | -44.0% |
| 2025 | Dec 31, 2025 | $215.37M | +332.5% |
| 2024 | Dec 31, 2024 | $49.80M | -46.5% |
| 2023 | Dec 29, 2023 | $93.08M | +378.9% |
| 2022 | Dec 30, 2022 | $19.44M | -84.4% |
| 2021 | Dec 31, 2021 | $124.73M | +213.1% |
| 2020 | Dec 31, 2020 | $39.84M | +68.8% |
| 2019 | Dec 31, 2019 | $23.60M | – |
| 2018 | Dec 31, 2018 | -$6.60M | -159.4% |
| 2017 | Dec 29, 2017 | $11.11M | +91.0% |
| 2016 | Dec 30, 2016 | $5.82M | -83.4% |
| 2015 | Dec 31, 2015 | $35.10M | -49.0% |
| 2014 | Dec 31, 2014 | $68.82M | – |
See a number that looks wrong?